Human Genome Sciences spurns GSK's $3B offer

Deborah Weinstein

April 19 2012

Human Genome Sciences rebuffed GlaxoSmithKline's advances Thursday with a press release that said, in essence, "Thanks for the $2.6 billion ...

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.